Cyclerion Therapeutics | 3: Initial statement of beneficial ownership of securities-Officer CHICKO RHONDA M.
Mar 11 16:09 ET
Cyclerion Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Tyndall Capital Partners, L.P.(6.7%)
Feb 14 16:15 ET
Cyclerion Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Invus Public Equities, L.P.(5.7%),Invus Public Equities Advisors, LLC(5.7%), etc.
Feb 9 17:10 ET
Cyclerion Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-FMR LLC(6.660%),Abigail P. Johnson(6.660%)
Feb 9 08:54 ET
Cyclerion Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Hecht Peter M
Jan 26 16:12 ET
Cyclerion Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Graul Regina Margaret
Jan 26 16:11 ET
Cyclerion Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Slate Path Capital LP(14.6%),David Greenspan(14.6%)
Jan 22 00:00 ET
Cyclerion Therapeutics | 3: Initial statement of beneficial ownership of securities-Director Katabi Dina
Dec 11, 2023 17:09 ET
Cyclerion Therapeutics | 3: Initial statement of beneficial ownership of securities-Director Higgins Michael J
Dec 7, 2023 16:05 ET
Cyclerion Therapeutics | 3/A: Initial statement of beneficial ownership of securities (Amendment)-President Graul Regina Margaret
Dec 7, 2023 16:05 ET
Cyclerion Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)
Dec 5, 2023 16:00 ET
Cyclerion Therapeutics | 3: Initial statement of beneficial ownership of securities-President Graul Regina Margaret
Dec 4, 2023 16:05 ET
Cyclerion Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director MCGUIRE TERRANCE
Dec 4, 2023 16:05 ET
Cyclerion Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Hecht Peter M
Dec 4, 2023 16:05 ET
Cyclerion Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director DESOUZA ERROL B
Dec 4, 2023 16:05 ET
Cyclerion Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Hyman Steven
Dec 4, 2023 16:04 ET
Cyclerion Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Tyndall Capital Partners, LP(5.05%)
Sep 5, 2023 16:05 ET
Cyclerion Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director MCGUIRE TERRANCE
Aug 11, 2023 16:25 ET
Cyclerion Therapeutics | D: Filing D
May 25, 2023 16:08 ET
Cyclerion Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)
May 23, 2023 16:00 ET
No Data
No Data